The in vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant Leishmania species of Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 106, Issue 4, 2011, Pages 475-478

  de Morais Teixeira, Eliane ^a   Damasceno, Quesia Souza ^a   Galuppo, Mariana Kolos ^a   Romanha, Alvaro José ^a   Rabello, Ana ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

In vitro drug evaluation; Leishmania; Miltefosine

Indexed keywords

LEISHMANIA AMAZONENSIS; LEISHMANIA BRAZILIENSIS; LEISHMANIA DONOVANI; LEISHMANIA DONOVANI CHAGASI; LEISHMANIA GUYANENSIS;

EID: 79959515043     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762011000400015     Document Type: Article

References (17)

1. Bhattacharya SK, Jha TK, Sundar S, Thakur CP, Engel J, Sindermann H, Junge K, Karbwang J, Bryceson ADM, Berman JD 2004. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. Clin Infect Dis 38: 217-221.
2. Croft SL, Snowdon D, Yardley V 1996. The activities of four anticancer alkyllsophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. J Antimicrob Chemother 38: 1041-1047.
3. Dey T, Afrin F, Anam K, Ali N 2002. Infectivity and virulence of Leishmania donovani promastigotes: a role for media, source and strain of parasite. J Eukaryot Microbiol 49: 270-274.
4. Escobar P, Matu S, Marques C, Croft SL 2002. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B. Acta Trop 81: 151-157.
5. Fischer C, Voss A, Engel J 2001. Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis. Med Microbiol Immunol 190: 85-87.
6. Huber W, Koella JC 1993. A comparison of three methods of estimating EC50 in studies of drugs resistance of malaria parasites. Acta Trop 55: 257-261.
7. Inocêncio da luz R, Vermeersch M, Dujardin JC, Cos P, Maes L 2009. In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophages host cells. Antimicrob Agents Chemother 53: 5197-5203.
8. Kaminsky R 2002. Miltefosine Zentaris. Curr Opin Investig Drugs 3: 550-554.
9. Le Fichoux Y, Rousseau D, Ferrua B, Ruette S, Lelièvre A, Grousson D, Kubar J 1998. Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice. Antimicrob Agents Chemother 42: 654-658.
10. Morais-Teixeira E de, Carvalho AS de, Costa JCS da, Duarte SL, Mendonça JS, Boechat N, Rabello A 2008. In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L. (L.) chagasi and L. (Viannia) braziliensis. Mem Inst Oswaldo Cruz 103: 358-362.
11. Ouellette M, Drummelsmith J, Papadopoulou B 2004. Leishmaniasis: drugs in the clinic, resistence and new developments. Drug Resist Updat 7: 257-266.
12. Paris C, Loiseau PM, Boris C, Bréard J 2004. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother 48: 852-859.
13. Schraner C, Hasse B, Hasse U, Baumann D, Faeh A, Burg G, Grimm F, Mathis A, Weber R, Günthard HF 2005. Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1. Clin Infect Dis 40: e120-e124.
14. Soto J, Arana A, Toledo J, Rizzo N, Vega JC, Diaz A, Luz M, Gutierrez P, Arboleda M, Berman JD, Junge K, Engel J, Sindermann H 2004. Miltefosine for New World cutaneous leishmaniasis. Clin Infect Dis 38: 1266-1272.
15. Sundar S, Rosenkaimer F, Makharia MK, Goyal AK, Mandal AK, Voss A, Hilgard P, Murray HW 1998. Trial of oral miltefosine for visceral leishmaniasis. Lancet 352: 1821-1823.
16. Weninger B, Robledo S, Arango GJ, Deharo E, Arango R, Munoz V, Callapa J, Lobstein A, Anton R 2001. Antiprotozoal activities of Colombian plants. J Ethnopharmacol 78: 193-200.
17. Yardley V, Croft SL, De Doncker S, Dujardin JC, Koirala S, Rijal S, Miranda C, Llanos-Cuentas A, Chappuis F 2005. The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine. Am J Trop Med Hyg 73: 272-275.